v3.26.1
Other interim disclosures (Tables)
6 Months Ended
Jun. 30, 2026
Disclosure of other interim disclosures [abstract]  
Disclosure of impairment loss and reversal of impairment loss [text block]
(USD millions)
Q2 2026
Q2 2025
H1 2026
H1 2025
Property, plant and equipment impairment charges
-4
-39
-6
Property, plant and equipment depreciation charge
-261
-241
-520
-456
Right-of-use assets impairment charges
-1
-1
Right-of-use assets depreciation charge
-77
-68
-150
-133
Intangible assets impairment charges
-199
-92
-199
-94
Intangible assets amortization charge
-862
-851
-1 719
-1 721
    
Disclosure of additions excluding the impact of business acquisitions [table text block]
(USD millions)
Q2 2026
Q2 2025
H1 2026
H1 2025
Additions to property, plant and equipment
335
349
610
559
Additions to right-of-use assets
102
81
151
137
Additions to intangible assets other than goodwill
408
198
852
1 377
Disclosure of detailed information about borrowings [table text block]

Coupon


Currency
Notional
amount
(millions)

Issuance
year

Maturity
year


Issuer


Issue price

USD
millions
SOFR + 0.65%
USD
500
2026
2029
Novartis Capital Corporation, New York, United States
100.000%
499
4.100%
USD
1 250
2026
2029
Novartis Capital Corporation, New York, United States
99.883%
1 247
4.400%
USD
1 750
2026
2031
Novartis Capital Corporation, New York, United States
99.960%
1 746
4.600%
USD
2 000
2026
2033
Novartis Capital Corporation, New York, United States
99.574%
1 986
4.900%
USD
2 250
2026
2036
Novartis Capital Corporation, New York, United States
99.719%
2 237
5.600%
USD
1 000
2026
2046
Novartis Capital Corporation, New York, United States
99.536%
990
5.700%
USD
2 250
2026
2056
Novartis Capital Corporation, New York, United States
99.120%
2 216
3.100%
EUR
600
2026
2032
Novartis Finance S.A., Luxembourg, Luxembourg
99.525%
679
3.500%
EUR
600
2026
2035
Novartis Finance S.A., Luxembourg, Luxembourg
99.757%
681
4.000%
EUR
500
2026
2041
Novartis Finance S.A., Luxembourg, Luxembourg
99.833%
568
Total straight and floating rate bonds issued in the first half of 2026
12 849
Total straight and floating rate bonds, June 30, 2026
40 542
Total straight and floating rate bonds, December 31, 2025
27 929
Research and development commitments

(USD millions)
Jun 30,
2026
2026
263
2027
1 888
2028
957
2029
1 494
2030
1 095
2031
1 213
Thereafter
12 813
Total
19 723